"Anti-Ulcer Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
| Descriptor ID |
D000897
|
| MeSH Number(s) |
D27.505.954.483.203
|
| Concept/Terms |
Anti-Ulcer Agents- Anti-Ulcer Agents
- Agents, Anti-Ulcer
- Anti Ulcer Agents
- Anti-Ulcer Drugs
- Anti Ulcer Drugs
- Drugs, Anti-Ulcer
|
Below are MeSH descriptors whose meaning is more general than "Anti-Ulcer Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Ulcer Agents".
This graph shows the total number of publications written about "Anti-Ulcer Agents" by people in this website by year, and whether "Anti-Ulcer Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Ulcer Agents" by people in Profiles.
-
Brandt NJ, Stefanacci RG. Discontinuation of unnecessary medications in older adults. Consult Pharm. 2011 Nov; 26(11):845-54.
-
Metz DC, Fulda GJ, Olsen KM, Monyak JT, Simonson SG, Sostek MB. Intravenous esomeprazole pharmacodynamics in critically ill patients. Curr Med Res Opin. 2010 May; 26(5):1141-8.
-
Farrell CP, Mercogliano G, Kuntz CL. Overuse of stress ulcer prophylaxis in the critical care setting and beyond. J Crit Care. 2010 Jun; 25(2):214-20.
-
Somberg L, Morris J, Fantus R, Graepel J, Field BG, Lynn R, Karlstadt R. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. J Trauma. 2008 May; 64(5):1202-10.
-
Vogiatzi P, Cassone M, Luzzi I, Lucchetti C, Otvos L, Giordano A. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies. J Cell Biochem. 2007 Oct 01; 102(2):264-73.
-
Abaza MM, Levy S, Hawkshaw MJ, Sataloff RT. Effects of medications on the voice. Otolaryngol Clin North Am. 2007 Oct; 40(5):1081-90, viii.
-
Hwang KO, Kolarov S, Cheng L, Griffith RA. Stress ulcer prophylaxis for non-critically ill patients on a teaching service. J Eval Clin Pract. 2007 Oct; 13(5):716-21.
-
Pratha V, Hogan DL, Lynn RB, Field B, Metz DC. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Dig Dis Sci. 2006 Sep; 51(9):1595-601.
-
Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006 Jul-Aug; 2(4):455-9.
-
Pratha VS, Hogan DL, Lane JR, Williams PJ, Burton MS, Lynn RB, Karlstadt RG. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Dig Dis Sci. 2006 Jan; 51(1):123-31.